All News

Educational programming for pharmacy students and practicing pharmacists on medication abortion is limited.

This week on Pharmacy Times, there are a number of important topics that will be covered and posted throughout the week.

According to the study, diets rich in fruits and vegetables help reduce the risk for numerous chronic health conditions that are leading causes of death, including cardiovascular disease and cancer.

Pharmacy Times® interviewed Chad Landmon, JD, chair of intellectual property and FDA practice groups at Axinn, Veltrop & Harkrider, on the FDA’s EUA process for COVID-19 vaccines.

The guidance said relaxing certain measures for vaccinated individuals may help improve COVID-19 vaccine acceptance and uptake.

Paul Ament, PharmD, reviews the data from studies looking into the prevention of VTEs and Riley Bowers, PharmD, shares the real-world data to the studies.

A panel of experts discuss the risks vs benefits of prophylactic care for patients to prevent VTE.

Paul Ament, PharmD, reviews the data from studies looking into the prevention of VTEs and Riley Bowers, PharmD, shares the real-world data to the studies.

The FDA has approved axicabtagene ciloleucel (Yescarta) for the treatment of adult patients with relapsed or refractory follicular lymphoma following 2 or more lines of systemic therapy.

The Pharmacy Times® Pharmacy Focus podcast provides the latest industry news and information, thought-leader insights, clinical updates, patient counseling tools, and innovative solutions for the everyday practice and business of pharmacy.

Heart failure is associated with a higher risk of cognitive decline and dementia.

New protein-based immunotherapies could stimulate patients’ immune systems without needing to engineer T cells on an individual basis.

The investigators urged continued safety measures, such as social distancing and school closures, in order to prevent more COVID-19 variant-related deaths and hospitalizations.

Through Walgreens Find Care®, patients can connect with local and national service providers through the convenience of the Walgreens mobile app or online.

Radiologists at Massachusetts General Hospital (MGH) have published an approach in the American Journal of Roentgenology to manage what they expect to be a fairly common occurrence as COVID-19 vaccination programs ramp up.

Due to new medications in discovery, the outcomes for patients with cancer are increasingly improving; however, the cost of this improved care is also increasing.

Investigators have found that the evolutionary sequence of insulin has become stuck at the edge of impaired production, limiting its ability to adapt to obesity and rendering most people vulnerable to type 2 diabetes.

Investigators are set to begin testing sulfasalazine and auronofin, which are FDA-approved to treat rheumatoid arthritis, in cancer cell models.

Research over the past decade has shown that PV can be associated with a reduction in survival compared with age- and gender-matched population controls.

Due to the high-touch, high-risk nature of specialty medications, specialty pharmacies must incorporate robust programs to ensure proper medication usage and minimize the potential for error or adverse events.

The study authors suggest that the biggest boost in risk reduction would stem from communication efforts aimed at raising awareness of COVID-19 risks among US adults under 40 years of age.

According to findings from a December 2020 national survey, more US adults reported receiving or planning to receive an influenza vaccination during the 2020-2021 flu season than ever before.

Previous studies have explored the benefits of vitamins D and C, as well as minerals such as zinc and magnesium, in fortifying the immune response against COVID-19.

The FDA has approved a supplemental new drug application for lorlatinib (Lorbrena) to expand the indication to include the frontline treatment of patients with ALK-positive non–small cell lung cancer.

Pharmacy Times® interviewed Sarah Browne, MD, senior director of vaccine development at Altimmune, on the commencement of a phase 1 clinical trial of a single-dose, intranasal COVID-19 vaccine.

In Vienna in the 1770s, a young physician named Franz Friedrich Anton Mesmer happened to meet a Jesuit priest named Maximilian Hell who was conducting medical experiments on patients with rheumatism.

Third party payers have concluded that the fee-for-service system is no longer financially viable and that a new approach is necessary.

Many rural areas identify with many barriers in their community, such as transportation, technology access, human factors, and the design of the health care model.